Skip to main content
HR 2433 114th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA)

To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.

Introduced: May 19, 2015 Introduced by: Bilirakis, Gus M. Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 19, 2015
Referred to the House Committee on Energy and Commerce.
May 19, 2015
Introduced in House
 Plain-English summary Congressional Research Service

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product.

What's happening now May 22, 2015

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2